# Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver Transplantation

> **NCT04475887** · PHASE4 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 60 (estimated)

## Conditions studied

- Liver Transplantation
- Blood Loss

## Interventions

- **DRUG:** Iron Carboxymaltose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04475887
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-23
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04475887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04475887, "Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver Transplantation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04475887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*